Background. There are no data on the prevalence of cytomegalovirus (CMV) shedding from a representative sample of the US population. This information is critical for understanding and preventing CMV.
Human cytomegalovirus (CMV) is a member of the herpesvirus family. A CMV-seronegative individual becomes immunoglobulin (Ig) G seropositive after initial infection with CMV (primary infection). The virus becomes latent in the host after primary infection but can reactivate periodically (reactivation) [1] . A seropositive person can also be infected with a different strain of CMV (reinfection), which may also become latent and subsequently reactivate. As a result of either primary or nonprimary infection (which includes reinfection and reactivation), individuals may shed CMV intermittently in body fluids such as saliva, urine, and genital secretions [2] and be infectious to others. Though most CMV infections are mild or asymptomatic, CMV infection can have serious clinical consequences in fetuses and immunocompromised individuals. Congenital CMV infection is the leading viral cause of birth defects and developmental disabilities in the United States [3] . An estimated 20 000 infants are born per year in the United States with congenital CMV infection [3] , resulting in around 4000 children with developmental neurologic disabilities each year [4] . Moreover, CMV is the most common opportunistic viral infection in individuals with immunosuppression and an important cause of morbidity [5, 6] .
CMV shedding has been well studied in immunocompromised populations, such as human immunodeficiency virusinfected individuals and organ transplant recipients [7] [8] [9] [10] [11] . Among immunocompetent populations, the frequency of CMV shedding has been studied in infants, young children, adolescents, women, men, and even in astronauts during spaceflights [12] [13] [14] [15] [16] [17] [18] . However, the sample sizes in these studies were small and the selected populations under study made it difficult to generalize findings to the general population. Here, we evaluated the archived urine specimens from the National Health and Nutrition Examination Survey (NHANES) 1999-2004 to provide population-based estimates of CMV shedding and explore risk factors associated with CMV shedding.
representative of the civilian noninstitutionalized household population of the United States [19] . CMV IgG status was previously determined for participants of NHANES 1999-2004 aged 6-49 years [20] . For the current study, available stored urine specimens were requested for the IgG-positive participants within 3 racial/ethnic groups: non-Hispanic white, non-Hispanic black, and Mexican American, as age-and sex-associated IgG seroprevalence was only available among these 3 racial groups [20] . As 14.8% CMV IgG-positive persons did not have urine specimens available, the examination weights were adjusted for the incomplete specimens after combination of the data from 3 cross-sectional waves of continuous NHANES (1999-2000, 2001-2002, and 2003-2004) . The new adjusted weights were created by multiplying the weighted proportion of available urine samples for that participant's sex, age, and race/ ethnicity with the weights calculated in the prior IgG seroprevalence study, which had also adjusted for the weighted proportion of available serum samples for each participant's age, race/ ethnicity, and sex group [20] . Publicly accessible data [21] on demographic characteristics associated with CMV IgG seroprevalence were used to examine the association with urinary CMV shedding. Sociodemographic characteristics were categorized as in a previous report on CMV IgG seroprevalence [20] . Household income was categorized by family poverty ratio, defined as the ratio of household income to the federal poverty threshold as low (<1.3), middle (1.3-3.5), or high (>3.5). The household crowding index was defined by the number of persons per room as low (<0.5), average (0.5-1), or high (>1) [20] . Individuals were categorized by age as children (6-11 years), adolescents (12-19 years) , or adults (20-49 years).
In NHANES 1999 NHANES -2004 , data on sexual behaviors were only available for adults (age ≥20 years). These data included age at first intercourse, number of lifetime sexual partners, number of sexual partners in the past year, number of sexual partners in past the month, number of instances of intercourse without a condom in the past month, and self-reported ever having been diagnosed with any of 4 sexually transmitted diseases (STDs): chlamydia, gonorrhea, genital herpes, or genital warts.
Urinary CMV Testing
DNA was extracted from urine specimens by treatment with the QIAamp MinElute Media kit (Qiagen, Valencia, California), then processed with the Qiacube automated extractor (Qiagen), following instructions that were customized by the manufacturer for processing urine. Detection of CMV DNA was performed with polymerase chain reaction assay (PCR) targeting the viral immediate early 2 (IE-2) region [22] using the MX 3005P Real-Time PCR system (Agilent Technologies, New Castle, Delaware). PCR testing was performed in duplicate for all specimens, and 2 positive results were required for specimens to be reported as positive. The commercially standardized human CMV DNA quantitated with digital PCR by Advanced Biotechnologies, Inc. (Eldersburg, Maryland) was included on every PCR plate to quantify the viral loads. The urinary CMV shedding and viral load data are publicly accessible [23] .
Statistical Analyses
The nationally representative prevalence estimates on urinary shedding were age standardized using the direct method to the 2000 projected US census population using the following age groups: 6-11, 12-19, and 20-49 years [24] . The age-adjusted estimates of urinary CMV shedding prevalence among all participants were examined to understand the force of infection in the population, assuming the untested CMV IgG-negative participants were free of urinary shedding. The estimates of shedding prevalence were also calculated among IgG-positive individuals to assess the prevalence of sources for transmission. All prevalence estimates were calculated using the aforementioned adjusted weights with SAS survey procedures (SAS Inc., Cary, North Carolina). Risk factors associated with CMV IgG seroprevalence, such as socioeconomic status and household crowding, were examined for their association with CMV urinary shedding after adjustment for age in a logistic regression model. The association of sexual behaviors with urinary CMV shedding was only examined in CMV IgG-positive adult participants. The urinary viral loads were log 10 transformed, and unweighted statistical methods were used to assess the distribution of viral loads across different risk factors examined in urinary shedding after adjustment for age.
The NCHS Research Ethics Review Board approved this study. Informed consent was obtained from all participants.
RESULTS

Prevalence of Urinary Shedding
Among 6828 urine specimens tested from CMV IgG-positive participants (of 13 001 NHANES participants with CMV IgG data within the 3 racial/ethnic groups studied), CMV DNA was detected in 537 specimens, for an overall age-adjusted prevalence of 3.83% (95% confidence interval [CI], 3.22-4.44). In contrast to the increased prevalence of IgG seropositivity with age (40.16%, 48.78%, and 60.21% in those aged 6-11, 12-19, and 20-49 years, respectively; P < .001 for trend), the prevalence of shedding significantly decreased with age (9.75%, 2.67%, and 1.87% in those aged 6-11, 12-19, and 20-49 years, respectively; P < .05 for all pairwise comparisons). The trend of decreasing shedding with age was consistent among all 3 racial/ ethnic groups ( Figure 1A ). Similar to the association with lower CMV IgG seroprevalence, lower prevalence of shedding was observed among non-Hispanic white, US-born persons and those with higher household income levels, higher household education levels, and low crowding indexes. No difference in urinary shedding was observed by sex or health insurance status (Table 1 ). When we restrict the analysis to CMV IgG-positive participants only, the age-adjusted prevalence of urinary shedding was 9.70% (95% CI, 8.43-10.98) among 6828 CMV IgG-positive participants tested for shedding. The prevalence of shedding significantly decreased with age, from 26.60% to 6.50% to 3.45% in those aged 6-11, 12-19, and 20-49 years, respectively (P < .001 for trend test and all pairwise comparisons). The trend of decreasing shedding prevalence with increasing age was consistent across the 3 racial/ethnic groups ( Figure 1B) . Shedding in IgG-positive females was higher than in males (10.26% vs 9.12%, P = .03). There were no differences in urinary shedding prevalence by race/ethnicity, country of birth, household income or education levels, health insurance status, and household crowding among CMV IgG-positive participants (Table 1) .
Sexual Behaviors and Urinary Shedding Among CMV IgG-Positive Participants
Among the 6828 CMV IgG-positive participants with urinary shedding data available, 3484 (56.4%) were aged 20-49 years; data on 4 sexual behavior variables were available for >85% of these participants. Based on weighted analyses, the number of sexual partners within the past year was significantly associated with urinary shedding (P = .02); however, there was no association of urinary CMV shedding with ever having had an STD, age at first sexual intercourse, or number of lifetime sexual partners (Table 2 ). More than 80% of the adults had missing information on the number of sexual partners and frequency of intercourse in the past month; therefore, these 2 variables could not be analyzed.
Urinary CMV Viral Loads
The average CMV viral load in urine was 2.74 log 10 copies/mL (95% CI, 2.68-2.80 log 10 copies/mL). The viral load decreased significantly with increasing age (mean, 2.87, 2.60, and 2.34 for those aged 6-11, 12-19, and 20-49 years, respectively; P < .001 for trend test and pairwise comparisons), and the same trend of decreasing viral loads with increasing age was observed in both males and females. Males had significantly higher viral loads than females (2.81 vs 2.69 log 10 copies/mL; P = .04), which was driven by children aged 6-11 years (3.10 vs 2.88 for males and females; P = .03; Figure 2 ). Moreover, there was no difference in viral load by sociodemographic factors such as race/ethnicity, country of birth, household income level, household education level, health insurance status, and household crowding index (Table 3 ).
DISCUSSION
We found that the prevalence of urinary CMV shedding was 3.83% among all participants and 9.70% among CMV IgGpositive persons aged 6-49 years in the United States. Both prevalence of CMV urinary shedding and viral loads decreased significantly with increasing age. To our knowledge, this study is the first to present prevalence estimates for CMV shedding based on a nationally representative sample of the US population. Moreover, the sample spans an age range from 6 to 49 years, which is wider than is typically studied. These findings enrich the literature on CMV shedding and provide reference values for future studies.
While it is well documented that exposure to children aged 1-4 years is an important risk factor for acquiring CMV infection [25] , our findings suggest that older children may also be an important source of CMV transmission. Though both primary and nonprimary CMV infection can lead to CMV shedding [26, 27] , shedding is more likely to occur after primary infection and is associated with longer duration of shedding and higher viral loads [2, 18, 28, 29] . Although CMV shedding in urine typically has higher viral loads than shedding in saliva [2, 29, 30] , urinary shedding is highly correlated with saliva shedding and can be considered a marker, with the caveat that CMV shedding in saliva probably presents more opportunities a Weighted estimates after adjustment for the availability of urine specimens.
b Self-report as ever diagnosed with genital herpes, genital warts, chlamydia, or gonorrhea.
for exposure and transmission than urine beyond the preschool age. Additionally, the higher CMV prevalence of shedding, higher viral loads, and lower IgG seroprevalence in adolescents compared to adults likely contribute to the higher prevalence and risk of congenital CMV infection seen among infants born to adolescent mothers [31] . We found that some sociodemographic factors associated with CMV seroprevalence [20] , such as race/ethnicity, household income level, education level, and household crowding index, were also statistically significantly associated with urinary shedding in all participants. However, when the analysis was restricted to IgG-positive participants, these associations were no longer significant. CMV IgG seroprevalence is determined by risk factors associated with primary CMV infection. In contrast, shedding results from both primary and nonprimary infection. The risk factors associated with nonprimary infection, particularly reactivation, are likely different from those associated with primary infection.
In addition, the only sexual risk factor we found associated with CMV shedding was a higher number of sexual partners in the past year. We did not detect any association between shedding and some other sexual behaviors that have been associated elsewhere with IgG seroprevalence, such as age at sexual debut, number of lifetime sexual partners, or ever having had an STD [32] . In a previous study, CMV shedding was more prevalent among STD clinic attendees [2] . An explanation for the associations seen between these other sexual risk factors and CMV shedding in previous studies may be that they were conducted in populations in which a greater proportion of participants had active STDs, a proxy for risky sexual behaviors leading to increased risk for primary infection/reinfection with CMV [2] . In contrast, the population sampled by NHANES may be at lower risk for having an active STD at the time of data collection.
Although rare, it is possible for CMV shedding to occur in IgG-negative individuals shortly after primary infection but before IgG appears. Therefore, our exclusion of IgG-negative participants might have led to a small underestimation of CMV urinary shedding prevalence, particularly among young participants who are more prone to experience primary infection. However, as the time interval between primary infection and IgG appearance is just a few weeks and overlaps with the time interval after primary infection but before shedding starts, the effect of underestimation would be small. Another limitation of this study is that the cross-sectional design of NHANES does not allow assessment of the duration or temporal pattern of shedding. Further, the lack of laboratory testing to distinguish primary and nonprimary infection makes it impossible to assess the relative contributions of primary vs nonprimary infection to CMV shedding. The findings from the current study may not be generalizable to other racial groups such as Asian and Pacific Islanders. Finally, self-reported sexual behaviors may be prone to some biases such as recall and social desirability biases [33] and result in underestimation of the role of sexual behaviors in CMV shedding. In summary, we found that the prevalence of urinary CMV shedding and viral loads decreased dramatically with age, which likely reflects the higher rates of primary CMV infection and longer duration of shedding among those of younger age. In addition to providing nationally representative estimates on CMV shedding prevalence and viral loads in the United States, our findings demonstrate that children aged >5 years continue to shed CMV at higher rates than adolescents and adults and may still be an important source of CMV transmission.
